MGNX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 13.00%

Insider Buying (Last 12 Months): $150,515.00

Insider Selling (Last 12 Months): $0.00

MacroGenics Insider Trading History Chart

MacroGenics Share Price & Price History

^$1.71

+0.30 (1.20%)

As of 02/13/2026 05:00 PM ET

Days: 30 | 90 | 365

MacroGenics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/20/2025	William K Heiden	Director	Buy	49,500	$1.49	$73,755.00	111,000
8/19/2025	William K Heiden	Director	Buy	50,500	$1.52	$76,760.00	61,500
4/4/2024	Jeffrey Stuart Peters	VP	Sell	51,395	$15.55	$799,192.25
2/26/2024	Jeffrey Stuart Peters	VP	Sell	16,124	$17.22	$277,655.28	8,895
2/1/2024	Ezio Bonvini	SVP	Sell	13,316	$15.00	$199,740.00	74,668
1/19/2024	Ezio Bonvini	SVP	Sell	13,316	$12.00	$159,792.00	87,984
12/20/2023	Ezio Bonvini	SVP	Sell	18,880	$10.08	$190,310.40	101,300
10/2/2023	Target N V Biotech	Major Shareholder	Buy	150,000	$4.46	$669,000.00	9,929,963
9/7/2023	Target N V Biotech	Major Shareholder	Buy	200,000	$5.26	$1,052,000.00	9,779,963
8/30/2023	Edward Hurwitz	Director	Buy	15,000	$4.91	$73,650.00	33,074
3/10/2023	Jeffrey Stuart Peters	VP	Sell	5,372	$6.03	$32,393.16
2/14/2023	Target N V Biotech	Major Shareholder	Buy	500,000	$5.07	$2,535,000.00	9,579,963

SEC Filings (Institutional Ownership Changes) for MacroGenics (NASDAQ:MGNX)

96.89% of MacroGenics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

MacroGenics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/13/2026	Marshall Wace LLP	1,284,563	$2.07M	0.0%	+104.0%	2.031%
2/13/2026	Walleye Capital LLC	33,180	$53K	0.0%	+31.8%	0.052%
2/13/2026	Affinity Asset Advisors LLC	484,308	$0.78M	0.0%	N/A	0.766%
2/13/2026	Jacobs Levy Equity Management Inc.	901,057	$1.45M	0.0%	+10.4%	1.424%
2/12/2026	Wasatch Advisors LP	1,786,356	$2.88M	0.0%	-8.4%	2.824%
2/12/2026	Jane Street Group LLC	1,254,923	$2.02M	0.0%	+48.2%	1.984%
2/12/2026	HRT Financial LP	190,095	$0.31M	0.0%	N/A	0.300%
2/12/2026	Renaissance Technologies LLC	2,908,631	$4.68M	0.0%	+71.0%	4.598%
2/12/2026	Dimensional Fund Advisors LP	187,775	$0.30M	0.0%	-45.7%	0.297%
2/11/2026	LPL Financial LLC	65,125	$0.11M	0.0%	+181.2%	0.103%
2/11/2026	XML Financial LLC	25,336	$41K	0.0%	-21.6%	0.040%
2/10/2026	Goldman Sachs Group Inc.	181,706	$0.29M	0.0%	-29.8%	0.287%
2/10/2026	Northwestern Mutual Wealth Management Co.	43,814	$71K	0.0%	+11,970.0%	0.069%
2/9/2026	Jefferies Financial Group Inc.	1,841,172	$2.96M	0.0%	N/A	2.910%
2/6/2026	Leonteq Securities AG	100,000	$0.16M	0.0%	N/A	0.158%
2/6/2026	GSA Capital Partners LLP	511,004	$0.82M	0.1%	+740.5%	0.808%
2/5/2026	AlphaCore Capital LLC	38,073	$61K	0.0%	N/A	0.060%
2/5/2026	Pinnacle Associates Ltd.	292,696	$0.47M	0.0%	-13.4%	0.463%
1/30/2026	R Squared Ltd	15,891	$26K	0.0%	N/A	0.025%
1/28/2026	Universal Beteiligungs und Servicegesellschaft mbH	300,000	$0.47M	0.0%	+42.9%	0.474%
1/1/2026	JPMorgan Chase & Co.	755,245	$1.27M	0.0%	+64.1%	1.194%
12/1/2025	Cantor Fitzgerald L. P.	160,000	$0.27M	0.0%	N/A	0.253%
11/17/2025	Jacobs Levy Equity Management Inc.	815,865	$1.37M	0.0%	-18.8%	1.291%
11/17/2025	Voleon Capital Management LP	307,395	$0.52M	0.0%	N/A	0.486%
11/17/2025	Wasatch Advisors LP	1,950,287	$3.28M	0.0%	-40.0%	3.086%
11/17/2025	Qube Research & Technologies Ltd	22,415	$38K	0.0%	N/A	0.035%
11/17/2025	Public Employees Retirement System of Ohio	42,382	$71K	0.0%	+63.1%	0.067%
11/17/2025	Millennium Management LLC	2,116,870	$3.56M	0.0%	+5.0%	3.349%
11/17/2025	Bank of America Corp DE	209,446	$0.35M	0.0%	+23.1%	0.331%
11/17/2025	Cantor Fitzgerald L. P.	160,000	$0.27M	0.0%	N/A	0.253%
11/17/2025	Algert Global LLC	88,130	$0.15M	0.0%	N/A	0.139%
11/17/2025	Ameriprise Financial Inc.	95,275	$0.16M	0.0%	-9.0%	0.151%
11/14/2025	Two Sigma Investments LP	437,091	$0.73M	0.0%	+7.3%	0.692%
11/14/2025	Bridgeway Capital Management LLC	88,700	$0.15M	0.0%	-33.7%	0.140%
11/14/2025	Squarepoint Ops LLC	385,633	$0.65M	0.0%	+595.0%	0.610%
11/13/2025	BNP Paribas Financial Markets	86,671	$0.15M	0.0%	+87.9%	0.137%
11/13/2025	Pinnacle Associates Ltd.	338,106	$0.57M	0.0%	-3.7%	0.535%
11/12/2025	Dimensional Fund Advisors LP	345,582	$0.58M	0.0%	-32.1%	0.547%
11/7/2025	GSA Capital Partners LLP	60,801	$0.10M	0.0%	N/A	0.096%
11/7/2025	Vanguard Group Inc.	4,224,234	$7.10M	0.0%	+0.3%	6.683%
11/7/2025	JPMorgan Chase & Co.	755,245	$1.27M	0.0%	+64.1%	1.195%
10/30/2025	Universal Beteiligungs und Servicegesellschaft mbH	210,000	$0.35M	0.0%	N/A	0.332%
10/23/2025	SG Americas Securities LLC	17,179	$29K	0.0%	+55.9%	0.027%
8/19/2025	State of Wyoming	31,557	$38K	0.0%	+41.8%	0.050%
8/15/2025	Rangeley Capital LLC	27,000	$33K	0.0%	N/A	0.043%
8/15/2025	EcoR1 Capital LLC	1,602,717	$1.94M	0.1%	N/A	2.540%
8/15/2025	Engineers Gate Manager LP	23,291	$28K	0.0%	N/A	0.037%
8/15/2025	BNP Paribas Financial Markets	46,132	$56K	0.0%	-56.1%	0.073%
8/15/2025	Bridgeway Capital Management LLC	133,700	$0.16M	0.0%	+16.1%	0.212%
8/15/2025	Bellevue Group AG	9,919,992	$12M	0.3%	-0.1%	15.724%
8/15/2025	Bank of America Corp DE	170,087	$0.21M	0.0%	-9.8%	0.270%
8/15/2025	Ameriprise Financial Inc.	104,751	$0.13M	0.0%	+99.8%	0.166%
8/14/2025	Jane Street Group LLC	758,204	$0.92M	0.0%	+207.7%	1.202%
8/14/2025	Armistice Capital LLC	5,960,000	$7.21M	0.1%	-5.3%	9.447%
8/14/2025	Sei Investments Co.	31,318	$38K	0.0%	N/A	0.050%
8/13/2025	Cresset Asset Management LLC	26,720	$32K	0.0%	+52.3%	0.042%
8/13/2025	Marshall Wace LLP	405,911	$0.49M	0.0%	+35.7%	0.643%
8/13/2025	Walleye Capital LLC	25,180	$30K	0.0%	N/A	0.040%
8/13/2025	Invesco Ltd.	61,032	$74K	0.0%	-10.7%	0.097%
8/13/2025	Quadrature Capital Ltd	21,105	$26K	0.0%	N/A	0.033%
8/13/2025	Russell Investments Group Ltd.	49,564	$59K	0.0%	+2,970.9%	0.079%
8/12/2025	JPMorgan Chase & Co.	460,137	$0.56M	0.0%	-38.2%	0.729%
8/12/2025	Catalyst Funds Management Pty Ltd	28,500	$34K	0.0%	N/A	0.045%
8/8/2025	Geode Capital Management LLC	683,538	$0.83M	0.0%	-53.1%	1.083%
8/7/2025	Acadian Asset Management LLC	2,491,703	$3.01M	0.0%	+7.9%	3.949%
8/7/2025	Connor Clark & Lunn Investment Management Ltd.	682,277	$0.83M	0.0%	-16.4%	1.081%
8/1/2025	Y Intercept Hong Kong Ltd	29,945	$36K	0.0%	N/A	0.047%
7/17/2025	XML Financial LLC	32,336	$39K	0.0%	+68.7%	0.051%
7/15/2025	Public Employees Retirement System of Ohio	25,982	$31K	0.0%	+261.8%	0.041%
6/27/2025	Goldman Sachs Group Inc.	197,696	$0.25M	0.0%	-43.7%	0.313%
6/18/2025	Voya Investment Management LLC	97,922	$0.12M	0.0%	+70.5%	0.155%
5/28/2025	Strs Ohio	207,200	$0.26M	0.0%	N/A	0.328%
5/21/2025	Acadian Asset Management LLC	2,308,649	$2.92M	0.0%	+78.8%	3.659%
5/19/2025	Jane Street Group LLC	246,427	$0.31M	0.0%	-21.9%	0.391%
5/16/2025	Goldman Sachs Group Inc.	197,696	$0.25M	0.0%	-43.7%	0.313%
5/16/2025	Jones Financial Companies Lllp	136,903	$0.17M	0.0%	+456,243.3%	0.217%
5/16/2025	Jacobs Levy Equity Management Inc.	665,351	$0.85M	0.0%	+17.6%	1.055%
5/16/2025	AQR Capital Management LLC	232,399	$0.30M	0.0%	-27.2%	0.368%
5/16/2025	Amundi	214,278	$0.27M	0.0%	N/A	0.340%
5/15/2025	Armistice Capital LLC	6,296,000	$8M	0.1%	+0.3%	9.979%
5/15/2025	State of Wyoming	22,262	$28K	0.0%	N/A	0.035%
5/13/2025	American Century Companies Inc.	39,525	$50K	0.0%	+236.6%	0.063%
5/12/2025	Nuveen LLC	198,470	$0.25M	0.0%	N/A	0.315%
5/12/2025	Invesco Ltd.	68,377	$87K	0.0%	+90.0%	0.108%
5/12/2025	Connor Clark & Lunn Investment Management Ltd.	816,054	$1.04M	0.0%	+9.6%	1.293%
5/9/2025	Deutsche Bank AG	51,093	$65K	0.0%	+3,803.2%	0.081%
5/8/2025	GSA Capital Partners LLP	448,530	$0.57M	0.1%	+81.9%	0.711%
5/6/2025	Pinnacle Associates Ltd.	476,496	$0.61M	0.0%	-5.1%	0.755%
4/29/2025	Bank of New York Mellon Corp	156,787	$0.20M	0.0%	-5.6%	0.249%
4/17/2025	Exchange Traded Concepts LLC	58,434	$74K	0.0%	+19.7%	0.093%
3/24/2025	Wellington Management Group LLP	323,857	$1.05M	0.0%	+5.4%	0.516%
2/18/2025	Frazier Life Sciences Management L.P.	3,175,665	$10.32M	0.4%	+5.5%	5.060%
2/17/2025	Vestal Point Capital LP	280,000	$0.91M	0.1%	-66.3%	0.446%
2/17/2025	Two Sigma Advisers LP	1,118,600	$3.64M	0.0%	+7.1%	1.782%
2/17/2025	Two Sigma Investments LP	860,745	$2.80M	0.0%	-2.6%	1.371%
2/17/2025	ProShare Advisors LLC	20,284	$66K	0.0%	+32.4%	0.032%
2/17/2025	Millennium Management LLC	2,864,721	$9.31M	0.0%	-19.0%	4.565%
2/17/2025	Lazard Asset Management LLC	9,869	$32K	0.0%	N/A	0.016%
2/17/2025	Cubist Systematic Strategies LLC	111,993	$0.36M	0.0%	N/A	0.178%
2/17/2025	Bridgeway Capital Management LLC	104,000	$0.34M	0.0%	N/A	0.166%

Data available starting January 2016

MacroGenics, Inc., a biopharmaceutical company, develops, manufactures, and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients with metastatic HER2-positive breast cancer who have received two or more prior anti-HER2 regimens. The company's pipeline of immuno-oncology product candidates includes MGC018, an antibody drug conjugate (ADC), which targets solid tumors expressing B7-H3; Enoblituzumab, a monoclonal antibody that targets B7-H3; and MGD024, an investigational bispecific CD123 × CD3 DART molecule to minimize cytokine-release syndrome for patients with hematologic malignancies. In addition, it develops Lorigerlimab, a monoclonal antibody that targets the immune checkpoints PD-1 and cytotoxic T-lymphocyte-associated protein 4; Tebotelimab, an investigational tetravalent DART molecule for PD-1 and lymphocyte-activation gene 3; Retifanlimab, a humanized monoclonal antibody targeting programmed death receptor-1; and IMGC936, an ADC that targets ADAM9, a cell surface protein over-expressed in various solid tumor types. Further, the company develops MGD014 and MGD020, a DART molecule to target the envelope protein of human immunodeficiency virus infected cells and CD3 on T cells; Teplizumab for the treatment of type 1 diabetes; and PRV-3279, a CD32B × CD79B DART molecule for the treatment of autoimmune indications. It has collaborations with Incyte Corporation; Zai Lab Limited; I-Mab Biopharma; and Janssen Biotech, Inc. The company was incorporated in 2000 and is headquartered in Rockville, Maryland.

Today's Range

Now: $1.71

$1.71

$1.78

50 Day Range

MA: $1.67

$1.33

$1.93

52 Week Range

Now: $1.71

$0.99

$2.95

Volume

233,659 shs

Average Volume

835,152 shs

Market Capitalization

$108.17 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.5

Who are the company insiders with the largest holdings of MacroGenics?: MacroGenics' top insider shareholders include:
William K Heiden (Director)
Jeffrey Stuart Peters (VP)
Learn More about top insider investors at MacroGenics.
Who are the major institutional investors of MacroGenics?: MacroGenics' top institutional investors include:
Renaissance Technologies LLC — 4.60%
Jefferies Financial Group Inc. — 2.91%
Wasatch Advisors LP — 2.82%
Jane Street Group LLC — 1.98%
Jacobs Levy Equity Management Inc. — 1.42%
GSA Capital Partners LLP — 0.81%
Learn More about top institutional investors of MacroGenics stock.
Which major investors are selling MacroGenics stock?: During the last quarter, MGNX stock was sold by these institutional investors:
Wasatch Advisors LP
Dimensional Fund Advisors LP
Goldman Sachs Group Inc.
Pinnacle Associates Ltd.
XML Financial LLC
Simplex Trading LLC
Which major investors are buying MacroGenics stock?: During the previous quarter, MGNX stock was purchased by institutional investors including:
Jefferies Financial Group Inc.
Renaissance Technologies LLC
GSA Capital Partners LLP
Jane Street Group LLC
HRT Financial LP
Leonteq Securities AG
Universal Beteiligungs und Servicegesellschaft mbH
Jacobs Levy Equity Management Inc.